Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study
Nom du journal : Clin Colorectal Cancer
Année : 2005
Volume : 5
Page de départ : 101
Page de fin : 107